Compounds > sobuzoxane
Page last updated: 2024-11-04

sobuzoxane and Leukemia, Lymphocytic, T Cell

sobuzoxane has been researched along with Leukemia, Lymphocytic, T Cell in 2 studies

sobuzoxane: used in treatment of leukemia L1210

Research Excerpts

ExcerptRelevanceReference
"Sobuzoxane (MST-16) is an analogue of ICRF-159 which was once evaluated on the clinical efficacies in England."2.39[A novel antitumor agent, sobuzoxane (MST-16)]. ( Tsukagoshi, S, 1994)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Taguchi, H1
Tsukagoshi, S1

Reviews

2 reviews available for sobuzoxane and Leukemia, Lymphocytic, T Cell

ArticleYear
[Treatment of adult T-cell leukemia].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1995, Volume: 22, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Camptothecin; Clinical

1995
[A novel antitumor agent, sobuzoxane (MST-16)].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:7

    Topics: Animals; Antineoplastic Agents; Clinical Trials, Phase II as Topic; Humans; Leukemia, Experimental;

1994